Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? Dear M.N.: When screening patients for ...

Zymo Research, a global leader in life science technologies, and STORI, a new women's health company, today announced a collaboration to bring a novel early pregnancy assay to market, enabling ...

Scientists have developed a simple and cost-effective blood test that shows promise for detecting multiple cancers, various ...

Revolutionary DNA test by BillionToOne could transform early cancer detection and prenatal screening in the US.

DEAR DR. ROACH: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? -- M.N. ANSWER: When screening patients ...

Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? — M.N. Answer: When screening patients ...

A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for ...